Teclistamab as an Effective Treatment for Pericardial Effusion in Relapsed Multiple Myeloma: Case Report and a Brief Literature Review
Bispecific antibodies, such as teclistamab, show great effectiveness as a treatment for patients with relapsed refractory multiple myeloma, including those with extramedullary disease.
Authors
- Sai Samyuktha Bandaru (ORCID: https://orcid.org/0000-0001-5466-2809)
- Naveen Singh Multani
- Cibar Benitez-Farina
- William Thomas Nauam
Institutions
- Ascension Providence Hospital (US)
- Providence Hospital (US)
- Michigan State University (US)
Publication Details
- Journal
- Case Reports in Oncology
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1159/000540979
- Citations
- 3
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.36
Funders
- Michigan State University
- College of Engineering, Michigan State University